jcm-logo

Journal Browser

Journal Browser

The New Era of Urological Surgery: Technology-Enhanced Clinical Outcomes

A special issue of Journal of Clinical Medicine (ISSN 2077-0383). This special issue belongs to the section "Nephrology & Urology".

Deadline for manuscript submissions: 20 December 2026 | Viewed by 1856

Editors


E-Mail Website
Guest Editor
1. Department of Morphological Sciences, Faculty of Medicine and Pharmacy, University of Oradea, 410073 Oradea, Romania
2. Pelican Hospital, Oradea, Romania
Interests: urology; anatomy; prostate cancer; kidney cancer; robotic surgery; urolithiasis

E-Mail Website
Guest Editor
Department of Urology, La Croix du Sud Hospital, Quint Fonsegrives, France
Interests: prostate cancer; robotic surgery; urology; oncology
Special Issues, Collections and Topics in MDPI journals

Special Issue Information

Dear Colleagues,

Urological surgery is undergoing a paradigm shift, with technological innovation increasingly central to advancing clinical practice and improving patient outcomes. The integration of robotic-assisted systems, advanced imaging modalities, augmented reality, artificial intelligence and precision instrumentation has enabled greater surgical accuracy, reduced perioperative morbidity, and broadened the applicability of minimally invasive approaches. These developments not only enhance oncological and functional results but also contribute to shorter recovery times and improved quality of life for patients. Concurrently, the incorporation of digital health tools, novel biomaterials, and perioperative optimization strategies is fostering more individualized and evidence-based surgical care. This Special Issue invites high-quality original research and reviews that critically examine the role of emerging technologies in shaping the future of urological surgery. Through a multidisciplinary lens, this collection aims to provide a comprehensive and authoritative overview of current advances and their translational impact on patient-centered care.

Dr. Razvan-George Rahota
Dr. Guillaume Ploussard
Guest Editors

Manuscript Submission Information

Manuscripts should be submitted online at www.mdpi.com by registering and logging in to this website. Once you are registered, click here to go to the submission form. Manuscripts can be submitted until the deadline. All submissions that pass pre-check are peer-reviewed. Accepted papers will be published continuously in the journal (as soon as accepted) and will be listed together on the special issue website. Research articles, review articles as well as short communications are invited. For planned papers, a title and short abstract (about 250 words) can be sent to the Editorial Office for assessment.

Submitted manuscripts should not have been published previously, nor be under consideration for publication elsewhere (except conference proceedings papers). All manuscripts are thoroughly refereed through a single-anonymized peer-review process. A guide for authors and other relevant information for submission of manuscripts is available on the Instructions for Authors page. Journal of Clinical Medicine is an international peer-reviewed open access semimonthly journal published by MDPI.

Please visit the Instructions for Authors page before submitting a manuscript. The Article Processing Charge (APC) for publication in this open access journal is 2600 CHF (Swiss Francs). Submitted papers should be well formatted and use good English. Authors may use MDPI's English editing service prior to publication or during author revisions.

Keywords

  • urology
  • surgery
  • robotic surgery
  • artificial intelligence
  • urological cancer

Benefits of Publishing in a Special Issue

  • Ease of navigation: Grouping papers by topic helps scholars navigate broad scope journals more efficiently.
  • Greater discoverability: Special Issues support the reach and impact of scientific research. Articles in Special Issues are more discoverable and cited more frequently.
  • Expansion of research network: Special Issues facilitate connections among authors, fostering scientific collaborations.
  • External promotion: Articles in Special Issues are often promoted through the journal's social media, increasing their visibility.
  • Reprint: MDPI Books provides the opportunity to republish successful Special Issues in book format, both online and in print.

Further information on MDPI's Special Issue policies can be found here.

Published Papers (1 paper)

Order results
Result details
Select all
Export citation of selected articles as:

Other

6 pages, 555 KB  
Brief Report
Assessment of Presence and Metastatic Involvement of Lymph Nodes in Anterior Periprostatic Fat (APPF) in Prostate Cancer Patients Treated with Robotic and Laparoscopic Radical Prostatectomy
by Mudassir Wani, Jayasimha Abbaraju, Bikram Bhattacharjee, Abdousamad Said Omar, Hasan Al-Chalabi and Sanjeev Madaan
J. Clin. Med. 2026, 15(12), 4614; https://doi.org/10.3390/jcm15124614 - 14 Jun 2026
Viewed by 904
Abstract
Introduction: Lymph nodes (LN) in the anterior periprostatic fat (APPF) may harbour metastatic disease in patients with Prostate Cancer (PCa). We investigated the incidence and significance of LN in APPF tissue removed during robotic and laparoscopic radical prostatectomy (RP). Patients and Methods [...] Read more.
Introduction: Lymph nodes (LN) in the anterior periprostatic fat (APPF) may harbour metastatic disease in patients with Prostate Cancer (PCa). We investigated the incidence and significance of LN in APPF tissue removed during robotic and laparoscopic radical prostatectomy (RP). Patients and Methods: We retrospectively analysed RP performed by a single surgeon from 2013 to 2023. A total of 670 patients underwent RP, with 407 procedures conducted laparoscopically and 263 robotically. Histological results were available for 509 patients, who were examined for the presence of LN and any evidence of metastatic involvement. Results: LN were detected in the periprostatic fat of eighty patients; however, only twelve had lymph node metastasis. Seven of the twelve patients presented with prostate-specific antigen (PSA) levels greater than 10 ng/mL. All LN-positive patients had a Gleason score of seven or higher. On MRI, all patients had a PIRADS score of four or higher, and eleven were staged at T3 or higher. Additionally, all twelve patients had a Briganti score exceeding twenty. Conclusions: Our series indicates that the APPF contains LN that can harbour metastatic disease. Patients can have LN involved in APPF without the involvement of pelvic LN. Therefore, our study suggests that routine excision of APPF should be considered for appropriate LN staging and to avoid missing any metastasis, and that scoring systems like Briganti should be used to help identify this high-risk group. Full article
Show Figures

Figure 1

Back to TopTop